Dr. Hassan Kaleem, MD

Dr. Kaleem practices at Oklahoma Surgical Hospital in Tulsa, Oklahoma, part of Oklahoma Surgical Hospital.

Dr. Kaleem's NPI, 1538315676, was assigned on August 8, 2008. Dr. Kaleem holds Oklahoma license 32816.

Dr. Kaleem's primary practice is Oklahoma Surgical Hospital, at 2408 East 81st Street, Suite 300, Tulsa, OK 74137 in Tulsa County. The practice phone is (918) 477-5000.

Dr. Kaleem's primary practice is Oklahoma Surgical Hospital in Tulsa, Oklahoma, part of Oklahoma Surgical Hospital. Dr. Kaleem is also affiliated with Saint Francis Hospital. The medical group on file is Oklahoma Cancer and Blood Specialists. Dmand AI also links Dr. Kaleem to 3 more hospitals, 3 medical groups, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaleem practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kaleem's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Kaleem's licenses on file in 4 states: Oklahoma, Iowa, Illinois and Texas.

CMS data shows 13,474 Medicare services from Dr. Kaleem across 20 procedure codes in 2024, for 271 Medicare patients. Medicare paid $296,062 for them. Every service was in an office.

CMS counts 271 Medicare patients who saw Dr. Kaleem in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaleem's median patient age at 59, with 70% women.

In 2024, Dr. Kaleem wrote 1,574 Medicare Part D claims for 215 patients. 47% of them were for generic drugs. CMS names the drug for 1,299 of them, across 41 drugs with 11 or more claims each, at $5,450,522 in total drug cost. In 2023, CMS named 813 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kaleem for performance year 2024, reported as part of a group. Dr. Kaleem accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaleem as offering telehealth.

Dmand AI links 1 paper to Dr. Kaleem in 2018. Dr. Kaleem's most frequent co-authors are Mohammed Mahmoud Milhem, MBBS and Varun Vijay Kumar Monga, MBBS, MD.

CMS Open Payments shows 1,378 general payments to Dr. Kaleem from 98 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 59% of the total. Pharmacosmos Therapeutics Inc. paid the most, $106,907.